https://ift.tt/2IVHF6y

The global brokerage firm said Sun Pharma was its top pick in its Indian healthcare coverage and sees 27 per cent upside potential in the stock

from Markets https://ift.tt/2xPucVP

Comments

Popular posts from this blog

IIT PhDs in demand for high-end R&D jobs

India Inc turn to non-bank routes for funding